Bank of Nova Scotia’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.7M | Sell |
27,607
-7,754
| -22% | -$3.44M | 0.02% | 425 |
|
|
2026
Q1 | $15.8M | Sell |
35,361
-62,559
| -64% | -$29.2M | 0.03% | 334 |
|
|
2025
Q4 | $44.4M | Buy |
97,920
+11,668
| +14% | +$5.03M | 0.07% | 214 |
|
|
2025
Q3 | $33.8M | Buy |
86,252
+36,643
| +74% | +$15.3M | 0.06% | 221 |
|
|
2025
Q2 | $22.1M | Buy |
49,609
+21,921
| +79% | +$10.1M | 0.05% | 247 |
|
|
2025
Q1 | $13.4M | Sell |
27,688
-19,409
| -41% | -$9.04M | 0.03% | 316 |
|
|
2024
Q4 | $19M | Sell |
47,097
-27,573
| -37% | -$12.8M | 0.03% | 297 |
|
|
2024
Q3 | $34.7M | Buy |
74,670
+23,303
| +45% | +$11.2M | 0.07% | 174 |
|
|
2024
Q2 | $24.1M | Sell |
51,367
-174,569
| -77% | -$75.8M | 0.05% | 238 |
|
|
2024
Q1 | $94.4M | Buy |
225,936
+163,589
| +262% | +$69.2M | 0.19% | 95 |
|
|
2023
Q4 | $25.4M | Buy |
62,347
+3,384
| +6% | +$1.25M | 0.05% | 263 |
|
|
2023
Q3 | $20.5M | Buy |
58,963
+33,942
| +136% | +$11.9M | 0.05% | 225 |
|
|
2023
Q2 | $8.81M | Buy |
25,021
+1,670
| +7% | +$563K | 0.02% | 300 |
|
|
2023
Q1 | $7.36M | Sell |
23,351
-19,317
| -45% | -$5.79M | 0.02% | 324 |
|
|
2022
Q4 | $12.3M | Buy |
42,668
+8,942
| +27% | +$2.73M | 0.03% | 318 |
|
|
2022
Q3 | $9.76M | Sell |
33,726
-31,302
| -48% | -$9.01M | 0.03% | 309 |
|
|
2022
Q2 | $18.3M | Buy |
65,028
+21,550
| +50% | +$5.77M | 0.04% | 285 |
|
|
2022
Q1 | $11.3M | Sell |
43,478
-57,781
| -57% | -$13.7M | 0.02% | 419 |
|
|
2021
Q4 | $22.2M | Sell |
101,259
-387,200
| -79% | -$75.3M | 0.03% | 367 |
|
|
2021
Q3 | $88.6M | Buy |
488,459
+447,537
| +1,094% | +$87.4M | 0.16% | 131 |
|
|
2021
Q2 | $8.25M | Sell |
40,922
-9,642
| -19% | -$2.02M | 0.02% | 488 |
|
|
2021
Q1 | $10.9M | Sell |
50,564
-69,477
| -58% | -$15.3M | 0.02% | 381 |
|
|
2020
Q4 | $28.4M | Buy |
120,041
+26,344
| +28% | +$6.04M | 0.06% | 245 |
|
|
2020
Q3 | $25.5M | Sell |
93,697
-322,893
| -78% | -$89.1M | 0.07% | 227 |
|
|
2020
Q2 | $121M | Buy |
416,590
+53,626
| +15% | +$14.5M | 0.42% | 63 |
|
|
2020
Q1 | $86.4M | Buy |
362,964
+302,317
| +498% | +$69.3M | 0.3% | 83 |
|
|
2019
Q4 | $13.3M | Buy |
60,647
+3,585
| +6% | +$726K | 0.03% | 342 |
|
|
2019
Q3 | $9.67M | Buy |
57,062
+8,974
| +19% | +$1.59M | 0.03% | 376 |
|
|
2019
Q2 | $8.82M | Sell |
48,088
-649
| -1% | -$113K | 0.04% | 314 |
|
|
2019
Q1 | $8.96M | Sell |
48,737
-20,015
| -29% | -$3.7M | 0.04% | 327 |
|
|
2018
Q4 | $11.4M | Buy |
68,752
+16,808
| +32% | +$2.91M | 0.05% | 254 |
|
|
2018
Q3 | $10M | Buy |
51,944
+23,977
| +86% | +$4.27M | 0.04% | 314 |
|
|
2018
Q2 | $4.75M | Sell |
27,967
-4,347
| -13% | -$674K | 0.03% | 355 |
|
|
2018
Q1 | $5.26M | Sell |
32,314
-7,395
| -19% | -$1.21M | 0.03% | 378 |
|
|
2017
Q4 | $5.95M | Sell |
39,709
-4,051
| -9% | -$600K | 0.03% | 381 |
|
|
2017
Q3 | $6.65M | Sell |
43,760
-72,499
| -62% | -$10.9M | 0.04% | 324 |
|
|
2017
Q2 | $15M | Buy |
116,259
+59,397
| +104% | +$7.15M | 0.08% | 219 |
|
|
2017
Q1 | $6.22M | Buy |
56,862
+51,357
| +933% | +$4.52M | 0.03% | 367 |
|
|
2016
Q4 | $406K | Buy |
5,505
+490
| +10% | +$39.9K | ﹤0.01% | 644 |
|
|
2016
Q3 | $437K | Buy |
5,015
+100
| +2% | +$9.45K | ﹤0.01% | 547 |
|
|
2016
Q2 | $423K | Buy |
4,915
+320
| +7% | +$27.6K | ﹤0.01% | 527 |
|
|
2016
Q1 | $365K | Buy |
4,595
+60
| +1% | +$5.43K | ﹤0.01% | 543 |
|
|
2015
Q4 | $571K | Buy |
4,535
+10
| +0.2% | +$1.21K | ﹤0.01% | 480 |
|
|
2015
Q3 | $471K | Buy |
4,525
+200
| +5% | +$25.7K | ﹤0.01% | 436 |
|
|
2015
Q2 | $534K | Buy |
4,325
+128
| +3% | +$16.1K | ﹤0.01% | 352 |
|
|
2015
Q1 | $495K | Buy |
4,197
+140
| +3% | +$16.8K | ﹤0.01% | 358 |
|
|
2014
Q4 | $482K | Hold |
4,057
| – | – | ﹤0.01% | 369 |
|
|
2014
Q3 | $456K | Buy |
4,057
+293
| +8% | +$27.9K | ﹤0.01% | 374 |
|
|
2014
Q2 | $356K | Buy |
3,764
+409
| +12% | +$28.7K | ﹤0.01% | 413 |
|
|
2014
Q1 | $237K | Buy |
3,355
+108
| +3% | +$8.55K | ﹤0.01% | 512 |
|
|
2013
Q4 | $241K | Buy |
3,247
+66
| +2% | +$4.6K | ﹤0.01% | 506 |
|
|
2013
Q3 | $241K | Buy |
+3,181
| New | +$253K | ﹤0.01% | 460 |
|
Other funds holding VRTX
Bank of Nova Scotia's VRTX Position: Q2 2026 in Review
Bank of Nova Scotia reduced its Vertex Pharmaceuticals (VRTX) stake by 22% in Q2 2026, selling an estimated $3.44M and leaving 27,607 shares worth $13.7M. The position accounts for 0.02% of the portfolio, ranked #425.
Bank of Nova Scotia first reported a position in VRTX in Q3 2013 and has held it in 52 quarters since. The position peaked at $121M in Q2 2020. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Bank of Nova Scotia held 27,607 shares of Vertex Pharmaceuticals worth $13.7M as of Q2 2026.
- Bank of Nova Scotia sold 7,754 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.44M.
- Vertex Pharmaceuticals made up 0.02% of Bank of Nova Scotia's portfolio in Q2 2026, its #425 holding.
- Bank of Nova Scotia first reported a position in Vertex Pharmaceuticals in Q3 2013 and has held it in 52 quarters since.
- Bank of Nova Scotia's Vertex Pharmaceuticals position peaked at $121M in Q2 2020.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.